Modern therapeutic approaches for the treatment of malignant liver tumours

H Petrowsky, R Fritsch, M Guckenberger… - Nature reviews …, 2020 - nature.com
Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Liver resection and transplantation for intrahepatic cholangiocarcinoma

V Mazzaferro, A Gorgen, S Roayaie, MD dit Busset… - Journal of …, 2020 - Elsevier
The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although
several advances have been made in the past decades to better understand this complex …

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

A Vogel, J Bridgewater, J Edeline… - Annals of …, 2023 - annalsofoncology.org
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ -
Annals of Oncology Skip to Main Content Advertisement Annals of Oncology European Society …

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

CL Bowlus, L Arrivé, A Bergquist, M Deneau… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐MITSUBA)

T Ioka, M Kanai, S Kobayashi, D Sakai… - Journal of Hepato …, 2023 - Wiley Online Library
Background Gemcitabine/cisplatin (GC) combination therapy has been the standard
palliative chemotherapy for patients with advanced biliary tract cancer (BTC). No …

Surgery for cholangiocarcinoma

U Cillo, C Fondevila, M Donadon, E Gringeri… - Liver …, 2019 - Wiley Online Library
Surgical resection is the only potentially curative treatment for patients with
cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic …

Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial

J Edeline, Y Touchefeu, B Guiu, O Farge… - JAMA …, 2020 - jamanetwork.com
Importance Patients with unresectable intrahepatic cholangiocarcinoma (ICC) have a poor
prognosis. Selective internal radiotherapy (SIRT) is a promising treatment option for hepatic …

Genetic determinants of outcome in intrahepatic cholangiocarcinoma

T Boerner, E Drill, LM Pak, B Nguyen, CS Sigel… - …, 2021 - Wiley Online Library
Background and Aim Genetic alterations in intrahepatic cholangiocarcinoma (iCCA) are
increasingly well characterized, but their impact on outcome and prognosis remains …

[HTML][HTML] Clinical treatment of cholangiocarcinoma: an updated comprehensive review

A Elvevi, A Laffusa, M Scaravaglio, RE Rossi… - Annals of …, 2022 - Elsevier
Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms of the bile ducts and
represents the second most common hepatic cancer after hepatocellular carcinoma; it is sub …

Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma

A Lauterio, R De Carlis, L Centonze, V Buscemi… - Cancers, 2021 - mdpi.com
Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …